ロード中...
GABA-ergic but not Anti-Cholinergic Agents Re-induce Clinical Deficits after Stroke
Our goal was to determine whether the excitatory (i.e., GABA) neurotransmitter system was important in human stroke recovery. We hypothesized that giving midazolam, a GABA(A) agonist, to patients would re-induce clinical deficits to a greater extent than the anti-cholinergic scopolamine. Twelve pati...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2849134/ https://ncbi.nlm.nih.gov/pubmed/20172537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2010.01.024 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|